These 3 drugmakers’ news sentiment consistently remains below industry average
FiND study showed that the news sentiment for 3 drug-makers from top 25 pharma companies consistently remained below the industry average for the past 12-months. FDC, Sun Pharma Advanced Research and Caplin Point Laboratories were 3 companies whose short-term, medium-term and long-term news sentiment consistently stayed below the industry average for the past 12-months.
In our view, below industry average news sentiment for a prolonged period of time does not augur well for the company. Corporate communications team can step up media engagement at the appropriate time by picking up early signals for deteriorating news coverage.
[Image 1: Short-term news sentiment (50-DMA)]
[Image 2: Medium-term news sentiment (100-DMA)]
[Image 3: Long-term news sentiment (200-DMA)]
FiND is a first of its platform offering high-end media analytics by tracking news coverage patterns and analyzing movement in underlying sentiment in real-time for all listed and unlisted companies globally. Our media analytics platform helps corporate communications/ public relations executives to:
#1. Track media presence and tonality of the company, CXOs, and brands
#2. Gather competitive intelligence and benchmark against peers
#3. Analyse the effectiveness of media campaigns
#4. Gauge media reception of new product launches/initiatives
To know more about, FiND Media Analytics, email us at firstname.lastname@example.org